Third generation sequencing analysis detects significant differences in duodenal microbiome composition between functional dyspepsia patients and control subjects

Background Functional dyspepsia (FD) is a multifactorial disorder as its development may be based on several different pathophysiological mechanisms. Interaction of gut microbiome with the host has been proposed as a potential mechanism involved in the disease's pathogenesis. Aim/Methods We aim...

Full description

Saved in:
Bibliographic Details
Published inNeurogastroenterology and motility Vol. 37; no. 1; pp. e14955 - n/a
Main Authors Tziatzios, Georgios, Stylianakis, Emmanouil, Damoraki, Georgia, Gkolfakis, Paraskevas, Leite, Gabriela, Mathur, Ruchi, Pimentel, Mark, Giamarellos‐Bourboulis, Evangelos J., Triantafyllou, Konstantinos
Format Journal Article
LanguageEnglish
Published England Wiley Subscription Services, Inc 01.01.2025
John Wiley and Sons Inc
Subjects
Online AccessGet full text
ISSN1350-1925
1365-2982
1365-2982
DOI10.1111/nmo.14955

Cover

Loading…
Abstract Background Functional dyspepsia (FD) is a multifactorial disorder as its development may be based on several different pathophysiological mechanisms. Interaction of gut microbiome with the host has been proposed as a potential mechanism involved in the disease's pathogenesis. Aim/Methods We aimed to characterize microbiome profiling on duodenal luminal content (DLC) of FD patients and compare it to that of controls (CG) and patients with irritable bowel syndrome (IBS). Outpatients fulfilling Rome IV criteria for FD, IBS, and control group (CG) underwent upper gastrointestinal endoscopy and 2 cc of duodenal aspirate (3rd – 4th part) was aspirated in sterile traps. Duodenal microbiome was assessed after DNA extraction and 16S gene–based sequencing on Oxford Nanopore MinION followed by EPI2ME analysis (ONT/Metrich‐ore Ltd). Bioanalysis of the microbiome (alpha‐, beta‐diversity, comparisons of relative abundances for all taxonomic ranks) was implemented in Python. Multiple group means comparisons were performed with one‐way Analysis of Variance (ANOVA) and Kruskal–Wallis test with Tuckey's and Dunn's post hoc tests respectively, in case of significance (P‐value <0.05). Results 20 subjects with FD (8 females; age 49.9 ± 13.5 yrs.), 20 with IBS (14 females; age 57.6 ± 14.8 yrs.) and 10 CG (6 females; age 49.2 ± 13.8 yrs.) had their DLC analyzed. The α‐diversity index of subjects with FD was significantly lower compared to controls (Shannon's index, p = 0.0218) and similar to that of patients with IBS. Principal Coordinate Analysis (PCoA) generated from species relative abundances (beta‐diversity) showed no difference in the DLC profile of subjects with FD and IBS when compared to controls (p = 0.513). Compared to controls, the relative abundance (RA) of Chloroflexota phylum was lower in subjects with FD (p = 0.017) and IBS (p = 0.026), respectively. Additionally, the RA of the Rhodothermota and Thermotogota phyla was lower in FD (p = 0.017 and p = 0.018, respectively) but not in IBS patients (p = 0.15 and p = 0.06, respectively) compared to controls. Interestingly, the RA of specific taxa from Chloroflexota, Rhodothermota and Thermotogota phyla were consistently lower in subjects with FD when compared to CG but similar to IBS, during analysis of all the subsequent major ranks of taxonomy. At the class level, there were significant differences in Syntrophobacteria, Acidithiobacillia, Cytophagia and Flavobacteriia between the FD and CG groups (p < 0.05), but no such difference between FD and IBS was found. Finally, multiple significant differences at the order, family, genus and species level between the FD and CG groups were also detected. A positive relationship between the RA of Streptococcus and those from genus Granulicatella was observed both in FD (p = 0.014) and IBS (p = 0.014) patients. Conclusion & Inferences The microbiome profiling from duodenal luminal content of FD patients is significantly different to that of controls, including lower microflora diversity, different microflora structure/composition and specific taxa. Similar differences in the DLC between FD and IBS patients were not evident. Third generation sequencing analysis detects significant differences in duodenal microbiome composition between functional dyspepsia patients and control subjects
AbstractList Functional dyspepsia (FD) is a multifactorial disorder as its development may be based on several different pathophysiological mechanisms. Interaction of gut microbiome with the host has been proposed as a potential mechanism involved in the disease's pathogenesis.BACKGROUNDFunctional dyspepsia (FD) is a multifactorial disorder as its development may be based on several different pathophysiological mechanisms. Interaction of gut microbiome with the host has been proposed as a potential mechanism involved in the disease's pathogenesis.We aimed to characterize microbiome profiling on duodenal luminal content (DLC) of FD patients and compare it to that of controls (CG) and patients with irritable bowel syndrome (IBS). Outpatients fulfilling Rome IV criteria for FD, IBS, and control group (CG) underwent upper gastrointestinal endoscopy and 2 cc of duodenal aspirate (3rd - 4th part) was aspirated in sterile traps. Duodenal microbiome was assessed after DNA extraction and 16S gene-based sequencing on Oxford Nanopore MinION followed by EPI2ME analysis (ONT/Metrich-ore Ltd). Bioanalysis of the microbiome (alpha-, beta-diversity, comparisons of relative abundances for all taxonomic ranks) was implemented in Python. Multiple group means comparisons were performed with one-way Analysis of Variance (ANOVA) and Kruskal-Wallis test with Tuckey's and Dunn's post hoc tests respectively, in case of significance (P-value <0.05).AIM/METHODSWe aimed to characterize microbiome profiling on duodenal luminal content (DLC) of FD patients and compare it to that of controls (CG) and patients with irritable bowel syndrome (IBS). Outpatients fulfilling Rome IV criteria for FD, IBS, and control group (CG) underwent upper gastrointestinal endoscopy and 2 cc of duodenal aspirate (3rd - 4th part) was aspirated in sterile traps. Duodenal microbiome was assessed after DNA extraction and 16S gene-based sequencing on Oxford Nanopore MinION followed by EPI2ME analysis (ONT/Metrich-ore Ltd). Bioanalysis of the microbiome (alpha-, beta-diversity, comparisons of relative abundances for all taxonomic ranks) was implemented in Python. Multiple group means comparisons were performed with one-way Analysis of Variance (ANOVA) and Kruskal-Wallis test with Tuckey's and Dunn's post hoc tests respectively, in case of significance (P-value <0.05).20 subjects with FD (8 females; age 49.9 ± 13.5 yrs.), 20 with IBS (14 females; age 57.6 ± 14.8 yrs.) and 10 CG (6 females; age 49.2 ± 13.8 yrs.) had their DLC analyzed. The α-diversity index of subjects with FD was significantly lower compared to controls (Shannon's index, p = 0.0218) and similar to that of patients with IBS. Principal Coordinate Analysis (PCoA) generated from species relative abundances (beta-diversity) showed no difference in the DLC profile of subjects with FD and IBS when compared to controls (p = 0.513). Compared to controls, the relative abundance (RA) of Chloroflexota phylum was lower in subjects with FD (p = 0.017) and IBS (p = 0.026), respectively. Additionally, the RA of the Rhodothermota and Thermotogota phyla was lower in FD (p = 0.017 and p = 0.018, respectively) but not in IBS patients (p = 0.15 and p = 0.06, respectively) compared to controls. Interestingly, the RA of specific taxa from Chloroflexota, Rhodothermota and Thermotogota phyla were consistently lower in subjects with FD when compared to CG but similar to IBS, during analysis of all the subsequent major ranks of taxonomy. At the class level, there were significant differences in Syntrophobacteria, Acidithiobacillia, Cytophagia and Flavobacteriia between the FD and CG groups (p < 0.05), but no such difference between FD and IBS was found. Finally, multiple significant differences at the order, family, genus and species level between the FD and CG groups were also detected. A positive relationship between the RA of Streptococcus and those from genus Granulicatella was observed both in FD (p = 0.014) and IBS (p = 0.014) patients.RESULTS20 subjects with FD (8 females; age 49.9 ± 13.5 yrs.), 20 with IBS (14 females; age 57.6 ± 14.8 yrs.) and 10 CG (6 females; age 49.2 ± 13.8 yrs.) had their DLC analyzed. The α-diversity index of subjects with FD was significantly lower compared to controls (Shannon's index, p = 0.0218) and similar to that of patients with IBS. Principal Coordinate Analysis (PCoA) generated from species relative abundances (beta-diversity) showed no difference in the DLC profile of subjects with FD and IBS when compared to controls (p = 0.513). Compared to controls, the relative abundance (RA) of Chloroflexota phylum was lower in subjects with FD (p = 0.017) and IBS (p = 0.026), respectively. Additionally, the RA of the Rhodothermota and Thermotogota phyla was lower in FD (p = 0.017 and p = 0.018, respectively) but not in IBS patients (p = 0.15 and p = 0.06, respectively) compared to controls. Interestingly, the RA of specific taxa from Chloroflexota, Rhodothermota and Thermotogota phyla were consistently lower in subjects with FD when compared to CG but similar to IBS, during analysis of all the subsequent major ranks of taxonomy. At the class level, there were significant differences in Syntrophobacteria, Acidithiobacillia, Cytophagia and Flavobacteriia between the FD and CG groups (p < 0.05), but no such difference between FD and IBS was found. Finally, multiple significant differences at the order, family, genus and species level between the FD and CG groups were also detected. A positive relationship between the RA of Streptococcus and those from genus Granulicatella was observed both in FD (p = 0.014) and IBS (p = 0.014) patients.The microbiome profiling from duodenal luminal content of FD patients is significantly different to that of controls, including lower microflora diversity, different microflora structure/composition and specific taxa. Similar differences in the DLC between FD and IBS patients were not evident.CONCLUSION & INFERENCESThe microbiome profiling from duodenal luminal content of FD patients is significantly different to that of controls, including lower microflora diversity, different microflora structure/composition and specific taxa. Similar differences in the DLC between FD and IBS patients were not evident.
Third generation sequencing analysis detects significant differences in duodenal microbiome composition between functional dyspepsia patients and control subjects
Functional dyspepsia (FD) is a multifactorial disorder as its development may be based on several different pathophysiological mechanisms. Interaction of gut microbiome with the host has been proposed as a potential mechanism involved in the disease's pathogenesis. We aimed to characterize microbiome profiling on duodenal luminal content (DLC) of FD patients and compare it to that of controls (CG) and patients with irritable bowel syndrome (IBS). Outpatients fulfilling Rome IV criteria for FD, IBS, and control group (CG) underwent upper gastrointestinal endoscopy and 2 cc of duodenal aspirate (3rd - 4th part) was aspirated in sterile traps. Duodenal microbiome was assessed after DNA extraction and 16S gene-based sequencing on Oxford Nanopore MinION followed by EPI2ME analysis (ONT/Metrich-ore Ltd). Bioanalysis of the microbiome (alpha-, beta-diversity, comparisons of relative abundances for all taxonomic ranks) was implemented in Python. Multiple group means comparisons were performed with one-way Analysis of Variance (ANOVA) and Kruskal-Wallis test with Tuckey's and Dunn's post hoc tests respectively, in case of significance (P-value <0.05). 20 subjects with FD (8 females; age 49.9 ± 13.5 yrs.), 20 with IBS (14 females; age 57.6 ± 14.8 yrs.) and 10 CG (6 females; age 49.2 ± 13.8 yrs.) had their DLC analyzed. The α-diversity index of subjects with FD was significantly lower compared to controls (Shannon's index, p = 0.0218) and similar to that of patients with IBS. Principal Coordinate Analysis (PCoA) generated from species relative abundances (beta-diversity) showed no difference in the DLC profile of subjects with FD and IBS when compared to controls (p = 0.513). Compared to controls, the relative abundance (RA) of Chloroflexota phylum was lower in subjects with FD (p = 0.017) and IBS (p = 0.026), respectively. Additionally, the RA of the Rhodothermota and Thermotogota phyla was lower in FD (p = 0.017 and p = 0.018, respectively) but not in IBS patients (p = 0.15 and p = 0.06, respectively) compared to controls. Interestingly, the RA of specific taxa from Chloroflexota, Rhodothermota and Thermotogota phyla were consistently lower in subjects with FD when compared to CG but similar to IBS, during analysis of all the subsequent major ranks of taxonomy. At the class level, there were significant differences in Syntrophobacteria, Acidithiobacillia, Cytophagia and Flavobacteriia between the FD and CG groups (p < 0.05), but no such difference between FD and IBS was found. Finally, multiple significant differences at the order, family, genus and species level between the FD and CG groups were also detected. A positive relationship between the RA of Streptococcus and those from genus Granulicatella was observed both in FD (p = 0.014) and IBS (p = 0.014) patients. The microbiome profiling from duodenal luminal content of FD patients is significantly different to that of controls, including lower microflora diversity, different microflora structure/composition and specific taxa. Similar differences in the DLC between FD and IBS patients were not evident.
Background Functional dyspepsia (FD) is a multifactorial disorder as its development may be based on several different pathophysiological mechanisms. Interaction of gut microbiome with the host has been proposed as a potential mechanism involved in the disease's pathogenesis. Aim/Methods We aimed to characterize microbiome profiling on duodenal luminal content (DLC) of FD patients and compare it to that of controls (CG) and patients with irritable bowel syndrome (IBS). Outpatients fulfilling Rome IV criteria for FD, IBS, and control group (CG) underwent upper gastrointestinal endoscopy and 2 cc of duodenal aspirate (3rd – 4th part) was aspirated in sterile traps. Duodenal microbiome was assessed after DNA extraction and 16S gene–based sequencing on Oxford Nanopore MinION followed by EPI2ME analysis (ONT/Metrich‐ore Ltd). Bioanalysis of the microbiome (alpha‐, beta‐diversity, comparisons of relative abundances for all taxonomic ranks) was implemented in Python. Multiple group means comparisons were performed with one‐way Analysis of Variance (ANOVA) and Kruskal–Wallis test with Tuckey's and Dunn's post hoc tests respectively, in case of significance (P‐value <0.05). Results 20 subjects with FD (8 females; age 49.9 ± 13.5 yrs.), 20 with IBS (14 females; age 57.6 ± 14.8 yrs.) and 10 CG (6 females; age 49.2 ± 13.8 yrs.) had their DLC analyzed. The α‐diversity index of subjects with FD was significantly lower compared to controls (Shannon's index, p = 0.0218) and similar to that of patients with IBS. Principal Coordinate Analysis (PCoA) generated from species relative abundances (beta‐diversity) showed no difference in the DLC profile of subjects with FD and IBS when compared to controls (p = 0.513). Compared to controls, the relative abundance (RA) of Chloroflexota phylum was lower in subjects with FD (p = 0.017) and IBS (p = 0.026), respectively. Additionally, the RA of the Rhodothermota and Thermotogota phyla was lower in FD (p = 0.017 and p = 0.018, respectively) but not in IBS patients (p = 0.15 and p = 0.06, respectively) compared to controls. Interestingly, the RA of specific taxa from Chloroflexota, Rhodothermota and Thermotogota phyla were consistently lower in subjects with FD when compared to CG but similar to IBS, during analysis of all the subsequent major ranks of taxonomy. At the class level, there were significant differences in Syntrophobacteria, Acidithiobacillia, Cytophagia and Flavobacteriia between the FD and CG groups (p < 0.05), but no such difference between FD and IBS was found. Finally, multiple significant differences at the order, family, genus and species level between the FD and CG groups were also detected. A positive relationship between the RA of Streptococcus and those from genus Granulicatella was observed both in FD (p = 0.014) and IBS (p = 0.014) patients. Conclusion & Inferences The microbiome profiling from duodenal luminal content of FD patients is significantly different to that of controls, including lower microflora diversity, different microflora structure/composition and specific taxa. Similar differences in the DLC between FD and IBS patients were not evident. Third generation sequencing analysis detects significant differences in duodenal microbiome composition between functional dyspepsia patients and control subjects
BackgroundFunctional dyspepsia (FD) is a multifactorial disorder as its development may be based on several different pathophysiological mechanisms. Interaction of gut microbiome with the host has been proposed as a potential mechanism involved in the disease's pathogenesis.Aim/MethodsWe aimed to characterize microbiome profiling on duodenal luminal content (DLC) of FD patients and compare it to that of controls (CG) and patients with irritable bowel syndrome (IBS). Outpatients fulfilling Rome IV criteria for FD, IBS, and control group (CG) underwent upper gastrointestinal endoscopy and 2 cc of duodenal aspirate (3rd – 4th part) was aspirated in sterile traps. Duodenal microbiome was assessed after DNA extraction and 16S gene–based sequencing on Oxford Nanopore MinION followed by EPI2ME analysis (ONT/Metrich‐ore Ltd). Bioanalysis of the microbiome (alpha‐, beta‐diversity, comparisons of relative abundances for all taxonomic ranks) was implemented in Python. Multiple group means comparisons were performed with one‐way Analysis of Variance (ANOVA) and Kruskal–Wallis test with Tuckey's and Dunn's post hoc tests respectively, in case of significance (P‐value <0.05).Results20 subjects with FD (8 females; age 49.9 ± 13.5 yrs.), 20 with IBS (14 females; age 57.6 ± 14.8 yrs.) and 10 CG (6 females; age 49.2 ± 13.8 yrs.) had their DLC analyzed. The α‐diversity index of subjects with FD was significantly lower compared to controls (Shannon's index, p = 0.0218) and similar to that of patients with IBS. Principal Coordinate Analysis (PCoA) generated from species relative abundances (beta‐diversity) showed no difference in the DLC profile of subjects with FD and IBS when compared to controls (p = 0.513). Compared to controls, the relative abundance (RA) of Chloroflexota phylum was lower in subjects with FD (p = 0.017) and IBS (p = 0.026), respectively. Additionally, the RA of the Rhodothermota and Thermotogota phyla was lower in FD (p = 0.017 and p = 0.018, respectively) but not in IBS patients (p = 0.15 and p = 0.06, respectively) compared to controls. Interestingly, the RA of specific taxa from Chloroflexota, Rhodothermota and Thermotogota phyla were consistently lower in subjects with FD when compared to CG but similar to IBS, during analysis of all the subsequent major ranks of taxonomy. At the class level, there were significant differences in Syntrophobacteria, Acidithiobacillia, Cytophagia and Flavobacteriia between the FD and CG groups (p < 0.05), but no such difference between FD and IBS was found. Finally, multiple significant differences at the order, family, genus and species level between the FD and CG groups were also detected. A positive relationship between the RA of Streptococcus and those from genus Granulicatella was observed both in FD (p = 0.014) and IBS (p = 0.014) patients.Conclusion & InferencesThe microbiome profiling from duodenal luminal content of FD patients is significantly different to that of controls, including lower microflora diversity, different microflora structure/composition and specific taxa. Similar differences in the DLC between FD and IBS patients were not evident.
Author Tziatzios, Georgios
Pimentel, Mark
Gkolfakis, Paraskevas
Triantafyllou, Konstantinos
Damoraki, Georgia
Giamarellos‐Bourboulis, Evangelos J.
Stylianakis, Emmanouil
Leite, Gabriela
Mathur, Ruchi
AuthorAffiliation 2 4th Department of Internal Medicine National and Kapodistrian University of Athens, Medical School Athens Greece
3 Medically Associated Science and Technology (MAST) Program Los Angeles California USA
1 Hepatogastroenterology Unit, Second Department of Internal Medicine—Propaedeutic, Research Institute and Diabetes Center, Medical School National and Kapodistrian University of Athens, “Attikon” University General Hospital Athens Greece
AuthorAffiliation_xml – name: 3 Medically Associated Science and Technology (MAST) Program Los Angeles California USA
– name: 1 Hepatogastroenterology Unit, Second Department of Internal Medicine—Propaedeutic, Research Institute and Diabetes Center, Medical School National and Kapodistrian University of Athens, “Attikon” University General Hospital Athens Greece
– name: 2 4th Department of Internal Medicine National and Kapodistrian University of Athens, Medical School Athens Greece
Author_xml – sequence: 1
  givenname: Georgios
  orcidid: 0000-0002-2945-6007
  surname: Tziatzios
  fullname: Tziatzios, Georgios
  organization: National and Kapodistrian University of Athens, “Attikon” University General Hospital
– sequence: 2
  givenname: Emmanouil
  surname: Stylianakis
  fullname: Stylianakis, Emmanouil
  organization: National and Kapodistrian University of Athens, Medical School
– sequence: 3
  givenname: Georgia
  surname: Damoraki
  fullname: Damoraki, Georgia
  organization: National and Kapodistrian University of Athens, Medical School
– sequence: 4
  givenname: Paraskevas
  surname: Gkolfakis
  fullname: Gkolfakis, Paraskevas
  organization: National and Kapodistrian University of Athens, “Attikon” University General Hospital
– sequence: 5
  givenname: Gabriela
  surname: Leite
  fullname: Leite, Gabriela
  organization: Medically Associated Science and Technology (MAST) Program
– sequence: 6
  givenname: Ruchi
  surname: Mathur
  fullname: Mathur, Ruchi
  organization: Medically Associated Science and Technology (MAST) Program
– sequence: 7
  givenname: Mark
  orcidid: 0000-0002-0619-5115
  surname: Pimentel
  fullname: Pimentel, Mark
  organization: Medically Associated Science and Technology (MAST) Program
– sequence: 8
  givenname: Evangelos J.
  orcidid: 0000-0003-4713-3911
  surname: Giamarellos‐Bourboulis
  fullname: Giamarellos‐Bourboulis, Evangelos J.
  organization: National and Kapodistrian University of Athens, Medical School
– sequence: 9
  givenname: Konstantinos
  orcidid: 0000-0002-5183-9426
  surname: Triantafyllou
  fullname: Triantafyllou, Konstantinos
  email: ktriant@med.uoa.gr
  organization: National and Kapodistrian University of Athens, “Attikon” University General Hospital
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39491051$$D View this record in MEDLINE/PubMed
BookMark eNp1kstu1TAQhi1URC-w4AWQJTawSOt7khWqKgpIhW7K2nLsyamPEjvYCdV5HZ60Tk-pAAlvxrK_-f_RzByjgxADIPSaklNazlkY4ykVrZTP0BHlSlasbdjBepekoi2Th-g45y0hRDGhXqBD3oqWEkmP0K-bW58c3kCAZGYfA87wY4FgfdhgE8ywyz5jBzPYOePsN8H33powY-f7HlIhIWMfsFuig8Lj0dsUOx9HwDaOU8z-QbaD-Q4g4H4Jdn0opNvlCabsDZ6KNYRiYIIrWWFOccB56bar60v0vDdDhleP8QR9v_x4c_G5urr-9OXi_KqygghZuRKMkMCMcYQzQ7iTqjGMy5pw3lBieNt1Sja1dWBZp6wwlNaNapiqa9XyE_Rhrzst3QjOloKSGfSU_GjSTkfj9d8_wd_qTfypKVWSCCaLwrtHhRRLE_OsR58tDIMJEJesOWW8IWVAtKBv_0G3cUmlKyslpCQto6vgmz9Leqrl9_wK8H4PlJ7nnKB_QijR627oshv6YTcKe7Zn7_wAu_-D-tvX633GPTgCvzQ
Cites_doi 10.21105/joss.01169
10.1038/s41592-019-0686-2
10.1093/database/baaa062
10.1111/nmo.14372
10.1159/000504090
10.3390/microorganisms8050691
10.14309/ajg.0000000000001197
10.1093/molbev/msw046
10.1093/femsec/fiab001
10.1159/000511944
10.1186/s12866-019-1617-1
10.1111/apt.15786
10.1136/gutjnl-2019-318536
10.1053/j.gastro.2016.02.011
10.3389/fimmu.2023.1242242
10.1136/gutjnl-2021-326158
10.1038/nrdp.2017.81
10.3389/fcimb.2020.00151
ContentType Journal Article
Copyright 2024 The Author(s). published by John Wiley & Sons Ltd.
2024 The Author(s). Neurogastroenterology & Motility published by John Wiley & Sons Ltd.
2024. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2024 The Author(s). published by John Wiley & Sons Ltd.
– notice: 2024 The Author(s). Neurogastroenterology & Motility published by John Wiley & Sons Ltd.
– notice: 2024. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7TK
K9.
7X8
5PM
DOI 10.1111/nmo.14955
DatabaseName Wiley Online Library Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Neurosciences Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE

ProQuest Health & Medical Complete (Alumni)
Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
DocumentTitleAlternate Tziatzios et al
EISSN 1365-2982
EndPage n/a
ExternalDocumentID PMC11650425
39491051
10_1111_nmo_14955
NMO14955
Genre researchArticle
Journal Article
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
123
1OB
1OC
24P
29N
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAKAS
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACUHS
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZCM
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFWVQ
AFZJQ
AHBTC
AHEFC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DTERQ
DU5
EAD
EAP
EAS
EBC
EBD
EBS
EBX
EJD
EMB
EMK
EMOBN
EPT
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
Q~Q
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
SV3
TEORI
TUS
UB1
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WIN
WOHZO
WOW
WQJ
WRC
WVDHM
WXI
WXSBR
XG1
YFH
ZZTAW
~IA
~WT
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7TK
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
K9.
7X8
5PM
ID FETCH-LOGICAL-c4045-dc40a45e2aad032a03d568a2357033810a39bb6587cdec2b6c4a1178682677693
IEDL.DBID 24P
ISSN 1350-1925
1365-2982
IngestDate Thu Aug 21 18:29:46 EDT 2025
Fri Jul 11 16:30:55 EDT 2025
Wed Aug 13 09:35:58 EDT 2025
Wed Feb 19 02:00:28 EST 2025
Tue Jul 01 00:43:40 EDT 2025
Wed Jan 22 17:11:56 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords functional
duodenal
microbiome
dyspepsia
Language English
License Attribution-NonCommercial-NoDerivs
2024 The Author(s). Neurogastroenterology & Motility published by John Wiley & Sons Ltd.
This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4045-dc40a45e2aad032a03d568a2357033810a39bb6587cdec2b6c4a1178682677693
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-2945-6007
0000-0002-0619-5115
0000-0002-5183-9426
0000-0003-4713-3911
OpenAccessLink https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fnmo.14955
PMID 39491051
PQID 3145509215
PQPubID 1006536
PageCount 8
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_11650425
proquest_miscellaneous_3123803651
proquest_journals_3145509215
pubmed_primary_39491051
crossref_primary_10_1111_nmo_14955
wiley_primary_10_1111_nmo_14955_NMO14955
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate January 2025
PublicationDateYYYYMMDD 2025-01-01
PublicationDate_xml – month: 01
  year: 2025
  text: January 2025
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Oxford
– name: Hoboken
PublicationTitle Neurogastroenterology and motility
PublicationTitleAlternate Neurogastroenterol Motil
PublicationYear 2025
Publisher Wiley Subscription Services, Inc
John Wiley and Sons Inc
Publisher_xml – name: Wiley Subscription Services, Inc
– name: John Wiley and Sons Inc
References 2020; 8
2019; 4
2021; 97
2023; 14
2017; 3
2020; 2020
2020; 52
2021; 39
2021; 116
2022; 34
2020; 17
2019; 19
2020; 69
2020; 101
2020; 10
2023; 72
2016; 150
2016; 33
e_1_2_12_4_1
e_1_2_12_3_1
e_1_2_12_6_1
e_1_2_12_5_1
e_1_2_12_19_1
e_1_2_12_18_1
e_1_2_12_2_1
e_1_2_12_17_1
e_1_2_12_16_1
e_1_2_12_15_1
e_1_2_12_14_1
e_1_2_12_13_1
e_1_2_12_12_1
e_1_2_12_8_1
e_1_2_12_11_1
e_1_2_12_7_1
e_1_2_12_10_1
e_1_2_12_9_1
References_xml – volume: 39
  start-page: 382
  issue: 4
  year: 2021
  end-page: 390
  article-title: High prevalence of small intestinal bacterial overgrowth among functional dyspepsia patients
  publication-title: Dig Dis
– volume: 3
  year: 2017
  article-title: Functional dyspepsia
  publication-title: Nat Rev Dis Prim
– volume: 19
  start-page: 239
  issue: 1
  year: 2019
  article-title: Optimizing microbiome sequencing for small intestinal aspirates: validation of novel techniques through the REIMAGINE study
  publication-title: BMC Microbiol
– volume: 10
  start-page: 151
  year: 2020
  article-title: Current sampling methods for gut microbiota: a call for more precise devices
  publication-title: Front Cell Infect Microbiol
– volume: 72
  start-page: 929
  issue: 5
  year: 2023
  end-page: 938
  article-title: Alterations to the duodenal microbiota are linked to gastric emptying and symptoms in functional dyspepsia
  publication-title: Gut
– volume: 14
  year: 2023
  article-title: Diversity of the microbiota communities found in the various regions of the intestinal tract in healthy individuals and inflammatory bowel diseases
  publication-title: Front Immunol
– volume: 17
  start-page: 261
  issue: 3
  year: 2020
  end-page: 272
  article-title: SciPy 1.0: fundamental algorithms for scientific computing in python
  publication-title: Nat Methods
– volume: 34
  issue: 11
  year: 2022
  article-title: Role of the duodenal microbiota in functional dyspepsia
  publication-title: Neurogastroenterol Motil
– volume: 97
  issue: 3
  year: 2021
  article-title: Is Oxford Nanopore sequencing ready for analyzing complex microbiomes?
  publication-title: FEMS Microbiol Ecol
– volume: 101
  start-page: 38
  issue: 1
  year: 2020
  end-page: 45
  article-title: Higher levels of streptococcus in upper gastrointestinal mucosa associated with symptoms in patients with functional dyspepsia
  publication-title: Digestion
– volume: 150
  start-page: 1380
  issue: 6
  year: 2016
  end-page: 1392
  article-title: Gastroduodenal Disorders
  publication-title: Gastroenterology
– volume: 33
  start-page: 1635
  issue: 6
  year: 2016
  end-page: 1638
  article-title: ETE 3: reconstruction, analysis, and visualization of Phylogenomic data
  publication-title: Mol Biol Evol
– volume: 116
  start-page: 935
  issue: 5
  year: 2021
  end-page: 942
  article-title: Small intestinal bacterial overgrowth in functional dyspepsia: a systematic review and meta‐analysis
  publication-title: Am J Gastroenterol
– volume: 69
  start-page: 591
  issue: 3
  year: 2020
  end-page: 600
  article-title: Novel concepts in the pathophysiology and treatment of functional dyspepsia
  publication-title: Gut
– volume: 8
  start-page: 691
  issue: 5
  year: 2020
  article-title: Gut microbiota Dysbiosis in functional dyspepsia
  publication-title: Microorganisms
– volume: 52
  start-page: 155
  issue: 1
  year: 2020
  end-page: 167
  article-title: Duodenal bacterial load as determined by quantitative polymerase chain reaction in asymptomatic controls, functional gastrointestinal disorders and inflammatory bowel disease
  publication-title: Aliment Pharmacol Ther
– volume: 2020
  year: 2020
  article-title: NCBI taxonomy: a comprehensive update on curation, resources and tools
  publication-title: Database
– volume: 4
  issue: 36
  year: 2019
  article-title: Scikit‐posthocs: pairwise multiple comparison tests in python
  publication-title: J Open Source Software
– ident: e_1_2_12_12_1
  doi: 10.21105/joss.01169
– ident: e_1_2_12_11_1
  doi: 10.1038/s41592-019-0686-2
– ident: e_1_2_12_9_1
  doi: 10.1093/database/baaa062
– ident: e_1_2_12_6_1
  doi: 10.1111/nmo.14372
– ident: e_1_2_12_19_1
  doi: 10.1159/000504090
– ident: e_1_2_12_5_1
  doi: 10.3390/microorganisms8050691
– ident: e_1_2_12_14_1
  doi: 10.14309/ajg.0000000000001197
– ident: e_1_2_12_10_1
  doi: 10.1093/molbev/msw046
– ident: e_1_2_12_8_1
  doi: 10.1093/femsec/fiab001
– ident: e_1_2_12_7_1
  doi: 10.1159/000511944
– ident: e_1_2_12_17_1
  doi: 10.1186/s12866-019-1617-1
– ident: e_1_2_12_13_1
  doi: 10.1111/apt.15786
– ident: e_1_2_12_4_1
  doi: 10.1136/gutjnl-2019-318536
– ident: e_1_2_12_2_1
  doi: 10.1053/j.gastro.2016.02.011
– ident: e_1_2_12_18_1
  doi: 10.3389/fimmu.2023.1242242
– ident: e_1_2_12_15_1
  doi: 10.1136/gutjnl-2021-326158
– ident: e_1_2_12_3_1
  doi: 10.1038/nrdp.2017.81
– ident: e_1_2_12_16_1
  doi: 10.3389/fcimb.2020.00151
SSID ssj0006246
Score 2.431325
Snippet Background Functional dyspepsia (FD) is a multifactorial disorder as its development may be based on several different pathophysiological mechanisms....
Functional dyspepsia (FD) is a multifactorial disorder as its development may be based on several different pathophysiological mechanisms. Interaction of gut...
BackgroundFunctional dyspepsia (FD) is a multifactorial disorder as its development may be based on several different pathophysiological mechanisms....
Third generation sequencing analysis detects significant differences in duodenal microbiome composition between functional dyspepsia patients and control...
SourceID pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage e14955
SubjectTerms Adult
Age
Chloroflexota
DNA sequencing
duodenal
Duodenum - microbiology
Dyspepsia
Dyspepsia - microbiology
Endoscopy
Female
Females
functional
Gastrointestinal Microbiome - genetics
Gastrointestinal Microbiome - physiology
Humans
Intestinal microflora
Irritable bowel syndrome
Irritable Bowel Syndrome - microbiology
Irritable Bowel Syndrome - physiopathology
Male
microbiome
Microbiomes
Middle Aged
Original
Relative abundance
Sequence analysis
Taxonomy
Variance analysis
Title Third generation sequencing analysis detects significant differences in duodenal microbiome composition between functional dyspepsia patients and control subjects
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fnmo.14955
https://www.ncbi.nlm.nih.gov/pubmed/39491051
https://www.proquest.com/docview/3145509215
https://www.proquest.com/docview/3123803651
https://pubmed.ncbi.nlm.nih.gov/PMC11650425
Volume 37
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3fa9RAEB5qBfFFtPVHtMooIr5Ectkfl-BTUUsRroq00Lewm93YPFzuaHoP_Xf6l3Zmswk9iuBLLrB7JGR2Zr6d_fZbgI8EgVhFzJGLO51K48u0NLVMhdSZt41qasMF_cWJPj6TP8_V-Q58HffCDPoQU8GNPSPEa3ZwY_s7Tt4tV18Y3qsH8JC31vIgz-XvKQzrfNhaJFSWEoxRUVaIaTzTX7eT0T2EeZ8oeRfAhgx09BSeROiIh4Otn8GO7_Zg_7CjafPyGj9hIHOGKvkePFrENfN9uDm9aC8d_g360mwGjPRpSlpooiYJOs-rCT0yn4PZQ_TBcTw8hUIJth26zYqCFL3Bsh3Um5YemZEeaV8YKV_IqXKoMKK77td-3bcGo35rT090GPnx2G8sl4H653B29OP023EaT2ZIa0kYMHX0Y6TyuTEuE7nJhFO6MCydkwnWDDOitJbAzbx2vs6trqWZzeaFpsnMnE9ffAG73arzrwBr7XLd2CbTdi6N8kXR2JpgXk0fXcyET-DDaKJqPQhwVOPEhexYBTsmcDAar4o-2FciaLCXhGkSeD81k_fwkojp_GrDfQiyUBJXswReDraeniJKSViKW4qtUTB1YGXu7ZauvQgK3axpxNEwgc9hwPz7zauTxa9w8_r_u76BxzmfQhwKQQewe3W58W8JGl3Zd8EF6Pr9T34LhI0Q0g
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Nb9QwEB2VIgEXBC0fgRYGhBCXoGzsOInEpapaLdBdOGyl3iIndmgOm1013UP_Dr-UGceJuqqQekokO0qUycw8j1_eAHwiCMQqYoZc3KhQapuHua5kKKSKbFkndaW5oD-bq-m5_HGRXOzAt-FfmF4fYiy4sWe4eM0OzgXpW17eLldfGd8nD-ChVHHKjRti-XuMwyru_y0SSRQSjkm8rhDzeMZLt7PRHYh5lyl5G8G6FHT6DJ567IhHvbGfw45t92D_qKV18_IGP6Njc7oy-R48mvlN8334u7hsrgz-cQLTbAf0_GnKWqi9KAkay9sJHTKhg-lD9MZx6J5CsQSbFs1mRVGKnmDZ9PJNS4tMSfe8L_ScL-Rc2ZcY0dx0a7vuGo1ewLWjOxr0BHnsNiXXgboXcH56sjiehr41Q1hJAoGhoYOWiY21NpGIdSRMojLN2jmRYNEwLfKyJHSTVsZWcakqqSeTNFO0mkm5_eJL2G1XrX0NWCkTq7qsI1WmUic2y-qyIpxX0UsXE2ED-DiYqFj3ChzFsHIhOxbOjgEcDMYrvBN2hXAi7DmBmgA-jMPkPrwnolu72vAcwiyUxZNJAK96W493EbkkMMUj2dZXME5gae7tkba5dBLdLGrE4TCAL-6D-f-TF_PZL3fy5v5T38Pj6WJ2Vpx9n_98C09ibknsqkIHsHt9tbGHhJOuy3fOHf4Bv68TVQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Nb9QwEB2VIlVcELR8BAoMCCEuQdnY8SbiVAGr8rFLD63UW2THTpvDZldN99C_wy9lxnGiriokTolkR4k8npnn8cszwHuCQKwiZsnFrYqldkVc6ErGQqrEmTqrK80F_flCHZ_JH-fZ-Q58Hv6F6fUhxoIbe4aP1-zga1vfcvJ2ufrE8D67B_d5s4-ndypPxjCs0v7XIpElMcGYLMgKMY1nfHQ7Gd1BmHeJkrcBrM9As0fwMEBHPOpt_Rh2XLsPB0ctLZuXN_gBPZnTV8n3YW8e9swP4M_pZXNl8cLrS7MZMNCnKWmhDpokaB3vJnTIfA5mD9GA43B4CoUSbFq0mxUFKfqCZdOrNy0dMiM90L4wUL6QU2VfYUR7063dums0Bv3Wjt5oMfDjsdsYLgN1T-Bs9u30y3EcTmaIK0kYMLZ00TJzqdY2EalOhM1Urlk6JxGsGaZFYQyBm2llXZUaVUk9mUxzRYuZKZ---BR221XrngNWyqaqNnWizFTqzOV5bSqCeRUNupgIF8G7wUTluhfgKIeFC9mx9HaM4HAwXhl8sCuF12AvCNNE8HZsJu_hLRHdutWG-xBkoSSeTSJ41tt6fIsoJGEpbsm3ZsHYgZW5t1va5tIrdLOmEUfDCD76CfPvLy8X89_-5sX_d30DeydfZ-Wv74ufL-FBygcS-5rQIexeX23cK0JJ1-a194a_HgsShw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Third+generation+sequencing+analysis+detects+significant+differences+in+duodenal+microbiome+composition+between+functional+dyspepsia+patients+and+control+subjects&rft.jtitle=Neurogastroenterology+and+motility&rft.au=Tziatzios%2C+Georgios&rft.au=Stylianakis%2C+Emmanouil&rft.au=Damoraki%2C+Georgia&rft.au=Gkolfakis%2C+Paraskevas&rft.date=2025-01-01&rft.issn=1365-2982&rft.eissn=1365-2982&rft.volume=37&rft.issue=1&rft.spage=e14955&rft_id=info:doi/10.1111%2Fnmo.14955&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1350-1925&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1350-1925&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1350-1925&client=summon